uz
Feedback
Medicine and surgery🫀🧠

Medicine and surgery🫀🧠

Kanalga Telegram’da o‘tish

Find me on twitter @ANHMM1418

Ko'proq ko'rsatish

📈 Telegram kanali Medicine and surgery🫀🧠 analitikasi

Medicine and surgery🫀🧠 (@medachool_summaries) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 22 732 obunachidan iborat bo'lib, Tibbiyot toifasida 972-o'rinni va Saudiya Arabistoni mintaqasida 3 089-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 22 732 obunachiga ega bo‘ldi.

08 Iyul, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni -81 ga, so‘nggi 24 soatda esa -3 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 8.61% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 2.04% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 1 957 marta ko‘riladi; birinchi sutkada odatda 463 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 1 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent المتجر, كورس, bloodstream, crbsi, effusion kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
Find me on twitter @ANHMM1418

Yuqori yangilanish chastotasi (oxirgi ma’lumot 09 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

22 732
Obunachilar
-324 soatlar
-367 kunlar
-8130 kunlar
Postlar arxiv
Repost from N/a
Sickle cell disease
Sickle cell disease

Repost from N/a
G6PD deficiency
G6PD deficiency

When to use ESA/EPO in CKD? —> if hgb <9-10 What is the target hgb? —> <11.5 (not higher !!, worse outcome) What
When to use ESA/EPO in CKD? —> if hgb <9-10 What is the target hgb? —> <11.5 (not higher !!, worse outcome) What is the pre-requisite? Iron —> Transferrin sat of 30% and ferritin 500 What is the contraindication? —> Stroke —> Active malignancy What is the route? pre-Hemodialysis stage —> oral then IV if failed HD patient —> IV right away What are the side effects? 1—> HTN 2—> Iron deficiency (consumed) 3—> Thrombosis (Heavy molecule) 4—>Bone pain (it worse on bone marrow !!) 5—> Pure red cell aplasia (due to antibodies against EPO) What are the causes of EPO resistance? 1—> factory problem (MDS, pure red cell plasia, myelofibrosis, Sickle cell) 2—> Product not available (B12, folate, iron deficiency) 3—> Ongoing problem (ongoing inflammation or malignancy) 4—> Machine problem (inadequate dialysis) 5—> miscellaneous (HIV, dialysis line infection, hyperparathyroidism)

Iron deficiency anemia
Iron deficiency anemia

Repost from N/a
manifestation of hypercalcemia
manifestation of hypercalcemia

Lymphadenopathy
Lymphadenopathy

Simplified version of solid pulmonary nodule 🔺When to repeat testing based on CT finding of SOLID pulmonary nodule 🔻
Simplified version of solid pulmonary nodule 🔺When to repeat testing based on CT finding of SOLID pulmonary nodule 🔻

Repost from N/a
🔰 Incidental pulmonary nodules: multiple solid nodules: ▫️ Low risk patients: 1️⃣ &lt; 6 mm 👉🏽 No follow up 2️⃣ 6-8 or mor
🔰 Incidental pulmonary nodules: multiple solid nodules: ▫️ Low risk patients: 1️⃣ < 6 mm 👉🏽 No follow up 2️⃣ 6-8 or more 👉🏽 Follow up in 3-6 months 👉🏽 then consider CT at 18-24 months ▫️High risk patients: 1️⃣ < 6 mm 👉🏽 Optional CT at 12 months 2️⃣ 6-8 or more 👉🏽 Follow up in 3-6 months 👉🏽 then consider CT at 18-24 months

🔺 Minimum duration of Dual Antiplatelet therapy (DAPT) post stent insertion 🔻 DAPT example: Aspirin + clopidogrel/ticagrelo
🔺 Minimum duration of Dual Antiplatelet therapy (DAPT) post stent insertion 🔻 DAPT example: Aspirin + clopidogrel/ticagrelor

Repost from N/a
VHD, valvular heart disease
VHD, valvular heart disease

Antiplatelets indications in TIA
Antiplatelets indications in TIA

Repost from N/a
TIA transient ischemic attack management
TIA transient ischemic attack management

SIADH
SIADH

🔬 فرصة نشر بحث طبي ✅ التخصص: Internal Medicine/Toxicology نوفر لك فرصة مشاركة ونشر بحث طبي بالاضافة للحصول على الكورسات التالية: 📘 CREB – Comprehensive Review of Epidemiology & Biostatistics يغطي أساسيات البحث الطبي: اختيار الفكرة، جمع وتحليل البيانات، وكتابة البحث 👥 العمل ضمن فريق بحثي ⏳ المقاعد محدودة ⛔️ 🛒 التسجيل عبر سلة (Medicine With Alis) واتساب للاستفسارات 📱: +966581216150 🔗 رابط التسجيل: https://salla.sa/medicine-with-alis

syphilis treatment
syphilis treatment

Repost from N/a
🔰 Lung cancer: paraneoplastic syndromes
🔰 Lung cancer: paraneoplastic syndromes

Repost from N/a
Hemochromatosis
Hemochromatosis

Repost from N/a
🔰 Effects of Phlebotomy in Hereditary Hemochromatosis
🔰 Effects of Phlebotomy in Hereditary Hemochromatosis

Repost from N/a
🔰 Hypoglycemia: Investigations
🔰 Hypoglycemia: Investigations